Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection.

Introduction: The COVID-19 pandemic has led to high demand of diagnostic tools. Rapid antigen detection tests have been developed and many have received regulatory acceptance such as CE IVD or FDA markings. Their performance needs to be carefully assessed.